These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27591924)

  • 1. Macrolides for Clinically Significant Bronchiectasis in Adults: Who Should Receive This Treatment?
    Hill AT
    Chest; 2016 Dec; 150(6):1187-1193. PubMed ID: 27591924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis?].
    Bochet M; Garin N; Janssens JP; Gerstel E
    Rev Med Suisse; 2011 Feb; 7(280):308, 310-2. PubMed ID: 21381275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.
    Fan LC; Lu HW; Wei P; Ji XB; Liang S; Xu JF
    BMC Infect Dis; 2015 Mar; 15():160. PubMed ID: 25888483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions.
    Haworth CS; Bilton D; Elborn JS
    Respir Med; 2014 Oct; 108(10):1397-408. PubMed ID: 25301290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.
    Wang D; Fu W; Dai J
    Medicine (Baltimore); 2019 Apr; 98(17):e15285. PubMed ID: 31027086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Wu Q; Shen W; Cheng H; Zhou X
    Respirology; 2014 Apr; 19(3):321-9. PubMed ID: 24417869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term macrolide treatment in adult chronic bronchial diseases: benefits and limits].
    Jouneau S; Desrues B
    Presse Med; 2014 May; 43(5):510-9. PubMed ID: 24631048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of non-cystic fibrosis bronchiectasis in children with a focus on the role of long-term treatment with macrolides.
    El Boustany P; Gachelin E; Colomban C; Cernoia J; Sudour P; Carsin A; Dubus JC
    Pediatr Pulmonol; 2019 Apr; 54(4):487-496. PubMed ID: 30652424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term macrolide treatment for non-cystic fibrosis bronchiectasis in children: a meta-analysis.
    Lee E; Sol IS; Kim JD; Yang HJ; Min TK; Jang GC; Hwang YH; Cho HJ; Suh DI; Kim K; Kim HS; Kim YH; Woo SI; Lee YJ; Jung S; Jeon YH
    Sci Rep; 2021 Dec; 11(1):24287. PubMed ID: 34930997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Gao YH; Guan WJ; Xu G; Tang Y; Gao Y; Lin ZY; Lin ZM; Zhong NS; Chen RC
    PLoS One; 2014; 9(3):e90047. PubMed ID: 24603554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of macrolides in childhood non-cystic fibrosis-related bronchiectasis.
    Masekela R; Green RJ
    Mediators Inflamm; 2012; 2012():134605. PubMed ID: 22570510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide treatment in patients with bronchiectasis: more attention should be paid to the number of exacerbations.
    Gao YH; Guan WJ; Xu G; Chen RC
    Pulm Pharmacol Ther; 2014 Apr; 27(2):213-4. PubMed ID: 24397907
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-Term Antibiotics in Bronchiectasis.
    Suarez-Cuartin G; Hernandez-Argudo M; Perea L; Sibila O
    Semin Respir Crit Care Med; 2021 Aug; 42(4):606-615. PubMed ID: 34261184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review.
    Shi ZL; Peng H; Hu XW; Hu JG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):171-8. PubMed ID: 24076368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological treatment of bronchiectasis.
    Melani AS; Lanzarone N; Rottoli P
    Expert Rev Clin Pharmacol; 2018 Mar; 11(3):245-258. PubMed ID: 29268637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term macrolide antibiotic therapy in the treatment of chronic small airway disease clinically mimicking diffuse panbronchiolitis.
    Kadota J; Mukae H; Mizunoe S; Kishi K; Tokimatsu I; Nagai H; Tomono K; Kohno S; Nasu M
    Intern Med; 2005 Mar; 44(3):200-6. PubMed ID: 15805707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology and treatment of bronchectasis].
    Turcanu AM; Mihăescu T
    Pneumologia; 2011; 60(1):26-9. PubMed ID: 21548197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical challenges in managing bronchiectasis.
    Tsang KW; Bilton D
    Respirology; 2009 Jul; 14(5):637-50. PubMed ID: 19659645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.